FNTA Antibody - N-terminal regio : FITC (ARP48520_P050-FITC)

Farnesyltransferase, CAAX box, alpha

FPTA, PTAR2, PGGT1A

2339

P49354

NP_001018197

Human, Mouse, Rat, Cow, Rabbit

The immunogen is a synthetic peptide directed towards the N terminal region of human FNTA

Prenyltransferases attach either a farnesyl group or a geranylgeranyl group in thioether linkage to the cysteine residue of protein's with a C-terminal CAAX box. CAAX geranylgeranyltransferase and CAAX farnesyltransferase are heterodimers that share the s

UBC; HK2; DYRK1A; RPL13A; SAFB2; TGM2; STAT2; INHBB; VAV2; HDAC6; PTP4A3; GBP1; CENPF; TGFBR1; TGFB1; KRAS; HRAS; RHOB; FNTB; ACVR1; PTP4A2

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB, IHC

Affinity Purified

0.5 mg/ml

Cow: 92%; Human: 100%; Mouse: 79%; Rabbit: 79%; Rat: 79%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

36kDa

Veluthakal, R., (2007) Diabetes 56 (1), 204-210

Wet Ice

312

FNTA

FNTA

Rabbit

NM_001018677

MAATEGVGEAAQGGEPGQPAQPPPQPHPPPPQQQHKEEMAAEAGEAVASP

Alpha